共 168 条
- [11] Blanpain C(2011)Cetuximab therapy for head and neck squamous cell carcinoma: a systematic review of the data Otolaryngol. Head Neck Surg. 144 676-684
- [12] Tang XH(2019)Immune checkpoint inhibitors for head and neck squamous cell carcinoma: current landscape and future directions Head Neck 41 4-18
- [13] Scognamiglio T(2015)YAP and TAZ: a nexus for Hippo signaling and beyond Trends Cell Biol. 25 499-513
- [14] Gudas LJ(2019)Hippo-YAP/TAZ signalling in organ regeneration and regenerative medicine Nat. Rev. Mol. Cell Biol. 20 211-226
- [15] Kutler DI(2019)YAP and TAZ: a signalling hub of the tumour microenvironment Nat. Rev. Cancer 19 454-464
- [16] Friedlander PL(2016)YAP/TAZ at the roots of cancer Cancer Cell 29 783-803
- [17] Chaturvedi AK(2015)The emerging roles of YAP and TAZ in cancer Nat. Rev. Cancer 15 73-79
- [18] Gillison ML(2015)Comprehensive genomic characterization of head and neck squamous cell carcinomas Nature 517 576-582
- [19] Chaturvedi AK(2018)Perspective on oncogenic processes at the end of the beginning of cancer genomics Cell 173 305-320.e310
- [20] Anderson WF(1998)Role of the p16 tumor suppressor gene in cancer J. Clin. Oncol. 16 1197-1206